natgillin/translations-raw huggingface dataset:
Inactivated porcine circovirus type 2 (PCV2)................................................ ≥ 2.1 log10 ELISA. Units Excipient:
Inaktiviran prašičji cirkovirus tip 2 (PCV2) ………………………………………. ≥ 2. 1 log10 ELIS. enot Dodatek:
Thiomersal................................................................................................................................. ..0.20 mg Adjuvant:
Tiomersal................................................................................................................ 0. 20 mg Pomožna snov:
494 to 501 mg
Parafin, tekoči ……………. …………………………………………….. … 494 do 501 mg
Pigs (gilts and sows).
Prašiči (mladice in svinje).
Passive immunisation of piglets via the colostrum, after active immunisation of sows and gilts, to reduce lesions in lymphoid tissues associated with PCV2 infection and as an aid to reduce PCV2- linked mortality.
Pasivna imunizacija prašičev s kolostrumom po cepljenju svinj in mladic z namenom zmanjšati lezije limfnega tkiva, ki jih je povzročila okužba s PCV2 kot pomoč za znižanje mortalnosti zaradi PCV2.
Apply usual aseptic procedures.
Potrebni so ukrepi, ki se običajno izvajajo pri ravnanju z živalmi.
2 Special precautions to be taken by the person administering the veterinary medicinal product to animals
2 Poslužujte se ukrepov za izvajanje asepse.
Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
Nenamerno injiciranje/ samo- injiciranje lahko povzroči hude bolečine in otekline, zlasti ob injiciranju v sklep ali prst, in lahko v izjemnih primerih, če ni zagotovljena takojšnja zdravniška oskrba, privede do izgube prizadetega prsta.
In clinical studies, the post-mortem examination of the injection sites performed at most 50 days after the vaccination revealed limited lesions such as a discoloration and a granuloma in the majority of animals, as well as necrosis or fibrosis in approximately half of the animals.
Preiskave na mestu dajanja cepiva post mortem največ 50 dni od cepljenja so pokazale omejene spremembe kot je sprememba barve tkiva in granulomi na mestu dajanja pri večini živali, kakor tudi nekroze ali fibroze pri približno polovici živali.
Within the 2 days following the injection, an average increase in rectal temperature of up to 1.4°C can occur.
V obdobju 2 dni po cepljenju se lahko pojavi zmerno zvišanje telesne temperature (povprečno do 1, 4˚C).
Rarely, an increase in rectal temperature of higher than 2.5°C, lasting less than 24 hours, may occur.
Redko se telesna temperatura zviša več kot 2, 5˚C, ki traja manj kot do 24 ur.
In rare cases, slight apathy or reduction in appetite may be observed, which should resolve spontaneously.
V redkih primerih opazimo apatijo in slabši apetit, ki spontano preideta.
In such cases, an appropriate symptomatic treatment should be provided.
V teh primerih je potrebno primerno simptomatsko zdravljenje.
Exceptionally abortion may occur after vaccination.
Po ceplenju lahko izjemoma pride do abortusa.
Use during lactation – not applicable.
Dajanje med laktacijo – navedba ni smiselna.
No information is available on the safety and efficacy from the concurrent use of this vaccine with any other.
Ni podatkov o varnosti in učinkovitosti ob sočasni uporabi tega cepiva s katerim koli drugim.
It is therefore recommended that no other vaccines should be administered concurrently within 14 days before or after vaccination with the product.
Zato odsvetujemo uporabo katerega koli cepiva v obdobju 14 dni pred ali po cepljenju s tem cepivom.
3 To use the vaccine, shake vigorously the vial of antigen suspension and inject its content into the vial of emulsion containing adjuvant.
Za pripravo cepiva dobro pretresite stekleničko s suspenzijo antigena in vsebino vbrizgajte v stekleničko z emulzijo nosilca.
Administer one 2 ml dose by deep intramuscular injection in accordance with the following vaccination scheme:
3 Odmerek po 2- ml dajte globoko intramuskularno, po naslednji shemi cepljenja:
Basic vaccination: • Gilts:
Prvo cepljenje: • Mladice:
One injection, followed 3 to 4 weeks later by a second injection, at least 2 weeks before mating.
2 injekciji v razmaku 3- 4 tedne, vsaj 2 tedna pred pripustitvijo.
One further injection must be given, at least 2 weeks before farrowing. • Sows:
Naslednji odmerek cepimo vsaj 2 tedna pred prasitvijo. • Svinje:
One injection, followed 3 to 4 weeks later by a second injection, at least 2 weeks before farrowing.
2 injekciji v razmaku 3- 4 tedne, vsaj 2 tedna pred prasitvijo.
Revaccination: • One injection at each gestation, at least 2 to 4 weeks before farrowing.
Ena injekcija v vsakem obdobju brejosti, vsaj 2 do 4 tedne pred prasitvijo.
No adverse reactions except those mentioned in section 4.6 were observed after the administration of a double dose of vaccine.
Po odmerjanju dvojnega odmerka cepiva ni bil opažen noben neželen učinek razen tistih, ki so omenjeni v poglavju 4. 6.
Swine inactivated viral vaccine ATC vet code:
ATC vet:
The reconstituted vaccine contains an inactivated porcine circovirus type 2 (PCV2) in an oily adjuvant (o/ w).
Pripravljeno cepivo vsebuje inaktiviran prašičji cirkovirus tipa 2 (PCV2), pomožna snov je oljnata (olje/ voda).
Light paraffin oil (Emulsion) Thiomersal (Suspension and Emulsion) Sorbitan oleate (Emulsion) Polysorbate 80 (Emulsion) Polysorbate 85 (Emulsion) Sodium chloride/ potassium dihydrogen phosphate/ disodium phosphate dihydrate (Suspension and Emulsion) Water for injections
(suspenzija in emulzija) sorbitan oleat (emulzija) polisorbat 80 (emulzija) polisorbat 85 (emulzija) natrijev klorid/ kalijev dihidrogenfosfat/ dinatrijev fosfat dihidrat (suspenzija in emulzija) voda za injekcije
Do not mix with any other medicinal product.
Ne mešajte z nobenim drugim cepivom ali imunološkim zdravilom.
4 6.3 Shelf life
6. 3 Rok uporabnosti
18 months as packaged for sale.
18 mesecev v originalni ovojnini.
Store and transport refrigerated (2 °C – 8 °C).
6. 4 Posebna navodila za shranjevanje 4 Shranjujte in prevažajte pri temperaturi (2 °C – 8 °C).
6.5 Nature and composition of immediate packaging
6. 5 Vrsta primarne ovojnine in vsebina
Type I glass vials with a butyl/ nitryl elastomer closures and sealed with an aluminium cap
Steklenička tip I z butil/ nitrilnim elastomernim zapiralom in aluminijastim pokrovčkom.
- 5 doses:
- 5 odmerkov:
1 vial of suspension (5 dose size) + 1 vial of emulsion (5 dose size).
1 steklenička suspenzije (5 odmerkov) + 1 steklenička emulzije (5 odmerkov)
- 10 x 5 doses:
- 10×5 odmerkov:
10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size).
10 stekleničk suspenzije (5 odmerkov) + 10 stekleničk emulzije (5 odmerkov)
- 25 doses:
- 25 odmerkov:
1 vial of suspension (25 dose size) + 1 vial of emulsion (25 dose size).
1 steklenička suspenzije (25 odmerkov) + 1 steklenička emulzije (25 odmerkov)
- 10 x 25 doses:
- 10×25 odmerkov:
10 vials of suspension (25 dose size) + 10 vials of emulsion (25 dose size).
10 stekleničk suspenzije (25 odmerkov) + 10 stekleničk emulzije (25 odmerkov)
The import, sale, supply and/ or use of Circovac is or may be prohibited in certain Member States on the whole or part of their territory pursuant to national animal health policy.
Uvoz, prodaja, oskrba in/ ali uporaba Circovaca je ali je lahko prepovedana v nekaterih državah članicah na njihovem celotnem ozemlju ali delu ozemlja v skladu z nacionalnim programom zdravstvenega varstva živali.
Any person intending to import, sell, supply and/ or use Circovac must consult the relevant Member State’ s competent authority on the current vaccination policies prior to the import, sale, supply and/ or use
Vsakdo, ki namerava uvažati, prodajati, oskrbovati in/ ali uporabljati Circovac, se mora posvetovati s pristojnimi organi posamezne države članice o veljavnih programih cepljenja še pred uvozom, prodajo, oskrbo in/ ali uporabo.
5 Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu
5 Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency, EMEA) http: // www. emea. europa. eu
MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE
IMETNIK DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROSTITEV SERIJE
Mérial, Laboratoire Porte des Alpes Rue de l'Aviation 69800 Saint Priest France
Mérial, Laboratoire Porte des Alpes Rue de l' Aviation 69800 Saint Priest France
Veterinary medicinal product subject to medical prescription.
Izdaja zdravila za uporabo v veterinarski medicini je le na recept
The following substances contained in the final product are included in Annex II of Council Regulation (EEC) No 2377/ 90:
NAVEDBA NAJVIŠJIH DOVOLJENIH KOLIČIN ZAOSTANKOV ZDRAVILA (MRL)
8 Substance Light liquid paraffin
8
MRL status Included in Annex II for all food producing species
V Dodatku II za vse živalske vrste, namenjene za prehrano ljudi
Comments Mineral hydrocarbons, low to high viscosity including microcrystalline waxes, approximately C10-C60; aliphatic, branched aliphatic and alicyclic compounds.
Mineralni hidrokarbonat, nizke do velike viskoznosti z vsebnostjo mikrokristalnih voskov, približno C10 - C60; alifatske, razvejane alifatske ali aliciklične sestave.
Thiomersal Adjuvant
Nosilec
Included in Annex II for all food producing species
V Dodatku II za vse živalske vrste, namenjene za prehrano ljudi
For use only as preservatives in multidose vaccines at a concentration not exceeding 0.02%.
Za uporabo le kot prezervativ v večodmernih vsebnikih cepiv v koncentraciji do 0. 02%.
Sorbitan oleate (sorbitan monoleate) Polysorbate 85 (Polyoxyethylene sorbitan trioleate)
polisorbat 85
Included in Annex II for all food producing species Included in Annex II for all food producing species
V Dodatku II za vse
11 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
11 PODATKI NA ZUNANJI OVOJNINI
5 doses:
5 odmerkov:
1 vial of suspension (5 dose size) + 1 vial of emulsion (5 dose size) 10 x 5 doses:
1 steklenička suspenzije (5 odmerkov) + 1 steklenička emulzije (5 odmerkov) 10×5 odmerkov:
10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size) 25 doses:
10 stekleničk suspenzije (5 odmerkov) + 10 stekleničk emulzije (5 odmerkov) 25 odmerkov:
1 vial of suspension (25 dose size) + 1 vial of emulsion (25 dose size) 10 x 25 doses:
1 steklenička suspenzije (25 odmerkov) + 1 steklenička emulzije (25 odmerkov) 10×25 odmerkov:
10 vials of suspension (25 dose size) + 10 vials of emulsion (25 dose size)
10 stekleničk suspenzije (25 odmerkov) + 10 stekleničk emulzije (25 odmerkov)
Circovac Emulsion and suspension for emulsion for injection for pigs
Emulzija in suspenzija za emulzijo za injiciranje za prašiče.
One reconstituted 2 ml dose contains:
NAVEDBA ZDRAVILNE( IH) UČINKOVIN( E) IN DRUGIH SNOVI
Passive immunisation of piglets to reduce lesions in lymphoid tissues and as an aid to reduce PCV2- linked mortality.
Pasivna imunizacija prašičev s kolostrumom po cepljenju svinj in mladic z namenom zmanjšati lezije limfnega tkiva, ki jih je povzročila okužba s PCV2 kot pomoč za znižanje mortalnosti zaradi PCV2.
EXP {month/ year} Use within 3 hours after mixing.
EXP Uporabite v 3 urah po rekonstituciji.
Protect from light.
Shranjujte in prevažajte pri temperaturi (2 °C – 8 °C), zaščitite pred svetlobo.
For animal treatment only – to be supplied only on veterinary prescription.
Oskrba le na podlagi veterinarskega recepta.
MERIAL 29 Avenue Tony Garnier F-69007 Lyon France
MERIAL 29 Avenue Tony Garnier F- 69007 Lyon France 13 16.
MARKETING AUTHORISATION NUMBER(S)
EU/ 2/ 07/ 075/ 001 EU/ 2/ 07/ 075/ 002 odmerkov)
EU/ 2/ 07/ 075/ 001 5 doses:
5 odmerkov:
1 vial of suspension (5 dose size) + 1 vial of emulsion (5 dose size) EU/ 2/ 07/ 075/ 002 10 x 5 doses:
1 steklenička suspenzije (5 odmerkov) + 1 steklenička emulzije (5 odmerkov) 10×5 odmerkov:
10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size) EU/ 2/ 07/ 075/ 003 25 doses:
EU/ 2/ 07/ 075/ 003 odmerkov)
1 vial of suspension (25 dose size) + 1 vial of emulsion (25 dose size)
1 steklenička suspenzije (25 odmerkov) + 1 steklenička emulzije (25
13 EU/ 2/ 07/ 075/ 004 10 x 25 doses:
EU/ 2/ 07/ 075/ 004 odmerkov)
10 vials of suspension (25 dose size) + 10 vials of emulsion (25 dose size)
10 stekleničk suspenzije (25 odmerkov) + 10 stekleničk emulzije (25
Vial of 5 doses of suspension Vial of 25 doses of suspension
Steklenička s 5 odmerki suspenzije Steklenička s 25 odmerki suspenzije
Circovac Suspension
Suspenzija.
EXP {month/ year}
EXP (mesec/ leto)
Vial of 5 doses of emulsion Vial of 25 doses of emulsion
Steklenička s 5 odmerki suspenzije Steklenička s 25 odmerki suspenzije
Circovac Emulsion
Emulzija.
Light paraffin oil and Thiomersal After reconstitution contains PCV2.
Po rekonstituciji vsebuje PCV2.
IM.
Pred uporabo preberite navodilo za uporabo. im
Withdrawal period:
Karenca: nič dni
Circovac Emulsion and suspension for emulsion for injection for pigs
Circovac Emulzija in suspenzija za emulzijo za injiciranje
Circovac Emulsion and suspension for emulsion for injection for pigs
Emulzija in suspenzija za emulzijo za injiciranje.
One reconstituted 2 ml dose contains:
En odmerek po 2 ml vsebuje:
Inactivated porcine circovirus type 2 (PCV2)................................................ ≥ 2.1 log10 ELISA. Units Excipient:
Inaktiviran prašičji cirko virus tip 2 (PCV2) ………………………………………. ≥ 2. 1 log10 ELISA. enot Dodatek:
Slight and transient local reactions normally occur after the administration of one dose of vaccine, mainly swelling (up to 2 cm2 in average) and redness (up to 3 cm2 in average), and in some cases oedema (up to 17 cm2 in average).
Po dajanju enega odmerka cepiva se lahko pojavijo zmerne in prehodne lokalne reakcije, predvsem kot oteklina (do 2 cm2 v povprečju) in rdečine (do 3 cm2 v povprečju) in v nekaterih primerih kot edemi (do 17 cm2 v 18 povprečju).
These reactions resolve spontaneously, in a maximum of 4 days on average, without any consequence on the health and the zootechnical performance of the sow or gilt.
Reakcije v povprečju spontano preidejo v največ 4 dneh brez posledic za zdravje in zootehnične rezultate.
18 In clinical studies, post-mortem examination of the injection sites performed at most 50 days after the vaccination revealed limited lesions such as a discoloration and a granuloma in the majority of animals as well as necrosis or fibrosis (in approximately half of the animals).
Preiskave na mestu dajanja cepiva post mortem največ 50 dni od cepljenja so pokazale omejene spremembe kot je sprememba barve tkiva in granulomi na mestu dajanja pri večini živali, kakor tudi nekroze ali fibroze pri približno polovici živali.
Within the 2 days following the injection, an average increase in rectal temperature up to 1.4°C can occur.
V obdobju 2 dni po cepljenju se lahko pojavi zmerno zvišanje telesne temperature (povprečno do 1, 4˚C).
In rare cases, slight apathy or reduction in appetite may be observed, which should resolve spontaneously.
V redkih primerih opazimo apatijo in slabši apetit, ki spontano preidejo.
To use the vaccine, shake vigorously the vial of suspension and inject its content into the vial of emulsion.
Za pripravo cepiva dobro pretresite stekleničko s suspenzijo antigena in vsebino vbrizgajte v stekleničko z emulzijo nosilca.
Administer one 2 ml dose by deep intramuscular injection in accordance with the following vaccination scheme:
Odmerek po 2- ml dajte globoko intramuskularno, po naslednji shemi cepljenja:
SPECIAL STORAGE PRECAUTIONS 19 Keep out of the reach and sight of children.
- Shranjujte nedosegljivo otrokom
Store and transport refrigerated (2 C – 8 C).
- Shranjujte in prevažajte pri temperaturi (2 °C – 8 °C), zaščitite pred svetlobo.
Use within 3 hours after mixing.
- Uporabite v 3 urah po rekonstituciji.
Do not use after the expiry date stated on the label.
- Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na ovojnini.
It is therefore recommended that no other vaccines should be administered concurrently within 14 days before or after vaccination with the product.
Zato odsvetujemo uporabo katerega koli cepiva v obdobju 14 dni pred ali po cepljenju s tem izdelkom.
No adverse reactions, except those mentioned in the section “ Adverse Reactions” were observed after the administration of a double dose of vaccine.
Po odmerjanju dvojnega odmerka cepiva ni bil opažen noben neželen učinek razen tistih, ki so omenjeni v poglavju » Neželeni učinki (pogostost in resnost) «.
Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu
Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency, EMEA) http: // www. emea. europa. eu
- 5 doses:
5 odmerkov:
1 vial of suspension (5 dose size) + 1 vial of emulsion (5 dose size).
1 steklenička suspenzije (5 odmerkov) + 1 steklenička emulzije (5 odmerkov) 10×5 odmerkov:
10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size).
10 stekleničk suspenzije (5 odmerkov) + 10 stekleničk emulzije (5 odmerkov) 25 odmerkov:
1 vial of suspension (25 dose size) + 1 vial of emulsion (25 dose size).
1 steklenička suspenzije (25 odmerkov) + 1 steklenička emulzije (25 odmerkov) 10×25 odmerkov:
To be supplied only on veterinary prescription.
Izdaja zdravila je le veterinarski recept.
Pharmaceutical Target Species form
Farmacevtska oblika
Route of administration
Ciljna Način živalska uporabe vrsta zdravila
HDPE bottle with child resistant closure
Steklenička (HDPE) zaprta z zamaškom, ki preprečuje otrokom odpiranje in zaščitnim pokrovom.
30 tablets and a 1 bottle in a desiccant sachet cardboard box
V steklenički je 30 Steklenička je v Navedba ni tablet in vrečica s kartonski škatli. smiselna silicagelom.
30 tablets and a 1 bottle in a desiccant sachet cardboard box
V steklenički je 30 Steklenička je v Navedba ni tablet in vrečica s kartonski škatli. smiselna silicagelom
What is Clomicalm?
Kaj je zdravilo Clomicalm?
Clomicalm is a veterinary medicine containing the active substance clomipramine.
Zdravilo Clomicalm je veterinarsko zdravilo, ki vsebuje zdravilno učinkovino klomipramin.
It is available as tablets containing 5 mg, 20 mg or 80 mg clomipramine.
Na voljo je v obliki tablet, ki vsebujejo 5 mg, 20 mg ali 80 mg klomipramina.
What is Clomicalm used for?
Za kaj se zdravilo Clomicalm uporablja?
Clomicalm is used as an aid in the treatment of dogs that have behavioural problems when separated from their owners, their normal home, or other dogs.
Zdravilo Clomicalm se uporablja kot pripomoček pri zdravljenju psov, ki imajo vedenjske motnje ob ločitvi od lastnikov, običajnega doma ali drugih psov.
These behavioural problems might be expressed for example by destructive behaviour or inappropriate defecation or urination in the house.
Te vedenjske motnje se lahko odražajo na primer kot uničevalno vedenje ali neprimerno odvajanje blata ali vode v hiši.
Clomicalm should not be used on its own but only in dogs that are also undergoing behavioural therapy.
Zdravilo Clomicalm se ne sme uporabljati samostojno in se lahko uporablja le pri psih, ki so hkrati vključeni v terapijo za spremembo vedenja.
Clomicalm tablets are given twice a day.
Tablete Clomicalm se dajejo dvakrat na dan.
The strength and number of tablet(s) to use is adjusted according to the dog’ s weight, so that the dog is given between 2 mg and 4 mg clomipramine per kg of the dog’ s bodyweight per day.
Jakost in število uporabljenih tablet je prilagojena telesni masi psa tako, da pes dnevno prejme od 2 do 4 mg klomipramina na kilogram svoje telesne mase.
The active substance in Clomicalm, clomipramine, belongs to the group of the tricyclic antidepressants.
Zdravilna učinkovina v zdravilu Clomicalm, klomipramin, pripada skupini tricikličnih antidepresivov.
In the body, clomipramine and its major metabolite, desmethylclomipramine prevent some neurotransmitters from being taken back up into nerve cells in the brain and spinal cord.
V telesu klomipramin in njegov največji metabolit, desmetilklomipramin, preprečujeta ponovno vračanje nekaterih nevrotransmiterjev v živčne celice v možganih in hrbtenjači.
Neurotransmitters are substances that transfer chemical signals from one nerve cell to another one.
Nevrotransmitorji so snovi, ki prenašajo kemične signale iz ene živčne celice v drugo.
Clomipramine prevents the re-uptake of serotonin (5-hydroxytryptamine) and desmethylclomipramine prevents the re-uptake of noradrenalin.
Klomipramin preprečuje ponovno prisvajanje serotonina (5- hidroksitriptamina) in desmetilklomipramin preprečuje ponovno prisvajanje noradrenalina.
Low levels of neurotransmitters in the central nervous system may be associated with depression, anxiety or aggression.
Nizke ravni nevrotransmiterjev v osrednjem živčnem sistemu povezujemo z depresijo, tesnobo ali nasilnim vedenjem.
By blocking the re-uptake of serotonin and noradrenalin into nerve cells, clomipramine and its metabolite allow the levels to remain higher.
Z zaviranjem ponovnega prisvajanja serotonina in noradrenalina v živčne celice, klomipramin in njegov metabolit omogočata, da ostanejo ravni višje.
This can improve the clinical signs (behavioural problems) in dogs with separation-related disorders.
To lahko izboljša klinične znake (vedenjske motnje) pri psih, ki imajo motnje, povezane z ločitvijo.
In order to treat a dog with anxiety, the animal should not only receive medicines but also behavioural therapy.
Psa z anksioznostjo je treba hkrati zdraviti z zdravili in vedenjsko terapijo.
Behavioural modification therapy is the most important part of therapy; however, the use of the medicine allows for a more speedy recovery of the animal patient.
Terapija za spremembo vedenja je najpomembnejši del zdravljenja, uporaba zdravila pa pospeši okrevanje živali.
How has Clomicalm been studied?
Kako je bilo zdravilo Clomicalm raziskano?
The effective dose of Clomicalm has been established in clinical studies in dogs.
Učinkovit odmerek zdravila Clomicalm je bil določen v kliničnih študijah na psih.
The efficacy and tolerance of the medicine in animal patients was confirmed in clinical studies in various veterinary practices or clinics in the USA, and in a number of countries in Europe (“ field studies”).
Učinkovitost in prenašanje zdravila pri bolnih živalih je bila potrjena v kliničnih študijah v različnih veterinarskih ambulantah in klinikah v ZDA ter v številnih držav v Evropi (preskušanja na terenu).
In each study, treatment with clomipramine was combined with behaviour modification techniques.
V vsaki študiji je bilo zdravljenje s klomipraminom kombinirano s tehnikami za spremembo vedenja.
The treatment results in these dogs were compared to treatment results in dogs receiving behavioural therapy alone (no medication).
Rezultati zdravljenja pri teh psih so bili primerjani z rezultati pri psih, ki so bili zdravljeni samo z vedenjsko terapijo (brez zdravil).
What benefit has Clomicalm shown during the studies?
Kakšne koristi je zdravilo Clomicalm izkazalo med študijami?
Results of the field studies indicated that the administration of clomipramine in combination with behaviour modification techniques was effective in the relief of clinical signs of separation anxiety.
Rezultati preskušanj na terenu kažejo, da je bila uporaba klomipramina v kombinaciji z tehnikami za spremembo vedenja učinkovita pri izboljševanju kliničnih znakov separacijske anksioznosti.
Treatment with clomipramine at twice daily doses of 1 - 2 mg/ kg bodyweight was effective, when compared to lower doses or to treatment with behavioural therapy alone (placebo).
Zdravljenje s klomipraminom dvakrat dnevno v odmerkih 1– 2 mg/ kg telesne mase je bilo učinkovito v primerjavi z nižjimi odmerki ali samo vedenjsko terapijo (placebo).
What is the risk associated with Clomicalm?
Kakšna tveganja so povezana z zdravilom Clomicalm?